Advanced Medical Solutions Group plc 21.3% potential upside indicated by Liberum Capital

Advanced Medical Solutions Group plc with ticker (LON:AMS) now has a potential upside of 21.3% according to Liberum Capital.



Liberum Capital set a target price of 296 GBX for the company, which when compared to the Advanced Medical Solutions Group plc share price of 233 GBX at opening today (23/03/2023) indicates a potential upside of 21.3%. Trading has ranged between 218 (52 week low) and 320 (52 week high) with an average of 349,624 shares exchanging hands daily. The market capitalisation at the time of writing is £491,311,116.

Advanced Medical Solutions Group plc is a United Kingdom-based company that specializes in the design, development, manufacture and distribution of tissue-healing technologies, including advanced wound care products, surgical dressings and medical grade materials as well as medical adhesives and sutures for closing and sealing tissue. It manufactures a range of products and materials that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats. The Company operates through two business units for its sales, marketing and research and development (R&D) activities, which include Surgical and Woundcare. Its Surgical business unit is focused on selling and marketing its branded products and are sold directly through its distributors. Its Woundcare business unit is focused on distribution and marketing its products that are supplied to medical device partners under its own brands. The Company offers its products under ActivHeal, LiquiBand and RESORBA brands.